Authors:
Kornstein, SG
Schatzberg, AF
Thase, ME
Yonkers, KA
McCullough, JP
Keitner, GI
Gelenberg, AJ
Ryan, CE
Hess, AL
Harrison, W
Davis, SM
Keller, MB
Citation: Sg. Kornstein et al., Gender differences in chronic major and double depression, J AFFECT D, 60(1), 2000, pp. 1-11
Authors:
Thase, ME
Friedman, ES
Berman, SR
Fasiczka, AL
Lis, JA
Howland, RH
Simons, AD
Citation: Me. Thase et al., Is cognitive behavior therapy just a 'nonspecific' intervention for depression? A retrospective comparison of consecutive cohorts treated with cognitive behavior therapy or supportive counseling and pill placebo, J AFFECT D, 57(1-3), 2000, pp. 63-71
Authors:
Thase, ME
Friedman, ES
Fasiczka, AL
Berman, SR
Frank, E
Nofzinger, EA
Reynolds, CF
Citation: Me. Thase et al., Treatment of men with major depression: A comparison of sequential cohortstreated with either cognitive-behavioral therapy or newer generation antidepressants, J CLIN PSY, 61(7), 2000, pp. 466-472
Authors:
Nofzinger, EA
Fasiczka, A
Berman, S
Thase, ME
Citation: Ea. Nofzinger et al., Bupropion SR reduces periodic limb movements associated with arousals fromsleep in depressed patients with periodic limb movement disorder, J CLIN PSY, 61(11), 2000, pp. 858-862
Citation: Je. Myers et Me. Thase, Anxiety in the patient with bipolar disorder: Recognition, significance, and approaches to treatment, PSYCHIAT AN, 30(7), 2000, pp. 456-464
Citation: Mb. Keller et al., Nefazodone, psychotherapy, and their combination for chronic depression - Reply, N ENG J MED, 343(14), 2000, pp. 1042-1043
Authors:
Keller, MB
McCullough, JP
Klein, DN
Arnow, B
Dunner, DL
Gelenberg, AJ
Markowitz, JC
Nemeroff, CB
Russell, JM
Thase, ME
Trivedi, MH
Zajecka, J
Blalock, JA
Borian, FE
Jody, DN
DeBattista, C
Koran, LM
Schatzberg, AF
Fawcett, J
Hirschfeld, RMA
Keitner, G
Miller, I
Kocsis, JH
Kornstein, SG
Manber, R
Ninan, PT
Rothbaum, B
Rush, AJ
Vivian, D
Rothbaum, B
Citation: Mb. Keller et al., A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression, N ENG J MED, 342(20), 2000, pp. 1462-1470
Authors:
McCullough, JP
Klein, DN
Keller, MB
Holzer, CE
Davis, SM
Kornstein, SG
Howland, RH
Thase, ME
Harrison, WM
Citation: Jp. Mccullough et al., Comparison of DSM-III-R chronic major depression and major depression superimposed on dysthymia (double depression): Validity of the distinction, J ABN PSYCH, 109(3), 2000, pp. 419-427
Authors:
Kornstein, SG
Schatzberg, AF
Thase, ME
Yonkers, KA
McCullough, JP
Keitner, GI
Gelenberg, AJ
Davis, SM
Harrison, WM
Keller, MB
Citation: Sg. Kornstein et al., Gender differences in treatment response to sertraline versus imipramine in chronic depression, AM J PSYCHI, 157(9), 2000, pp. 1445-1452
Citation: F. Lotufo-neto et al., Meta-analysis of the reversible inhibitors of monoamine oxidase type A moclobemide and brofaromine for the treatment of depression, NEUROPSYCH, 20(3), 1999, pp. 226-247
Authors:
Cornelius, JR
Perkins, KA
Salloum, IM
Thase, ME
Moss, HB
Citation: Jr. Cornelius et al., Fluoxetine versus placebo to decrease the smoking of depressed alcoholic patients, J CL PSYCH, 19(2), 1999, pp. 183-184
Authors:
Klein, DN
Schatzberg, AF
McCullough, JP
Dowling, F
Goodman, D
Howland, RH
Markowitz, JC
Smith, C
Thase, ME
Rush, AJ
LaVange, L
Harrison, WM
Keller, MB
Citation: Dn. Klein et al., Age of onset in chronic major depression: relation to demographic and clinical variables, family history, and treatment response, J AFFECT D, 55(2-3), 1999, pp. 149-157
Citation: Me. Thase et Es. Friedman, Is psychotherapy an effective treatment for melancholia and other severe depressive states?, J AFFECT D, 54(1-2), 1999, pp. 1-19